Mark Heinen

Insider Reports History

Entity
Individual
Location
548 Market Street, #49404, San Francisco, CA
Signature
/s/ Jennifer Liotta, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Heinen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Volato Group, Inc. Chief Financial Officer Common Stock 148K $111K $0.75 Jun 7, 2024 Direct
Better Therapeutics, Inc. Chief Financial Officer Common Stock 140K $23.7K $0.17 Apr 5, 2023 Direct
Better Therapeutics, Inc. Chief Financial Officer Common Stock 2.28K $387 $0.17 Mar 1, 2023 By daughter
Volato Group, Inc. Chief Financial Officer Performance-Based Restricted Stock Unit 47.8K Jun 7, 2024 Direct
Better Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 28.6K Mar 1, 2023 Direct

Insider Reports Filed by Mark Heinen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SOAR Volato Group, Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Chief Financial Officer
SOAR Volato Group, Inc. Jun 6, 2024 1 $6.8K 4 Jun 10, 2024 Chief Financial Officer
SOAR Volato Group, Inc. Dec 1, 2023 0 $0 3 Dec 19, 2023 Chief Financial Officer
BTTX Better Therapeutics, Inc. Mar 1, 2023 2 $0 4 Apr 21, 2023 Chief Financial Officer
BTTX Better Therapeutics, Inc. Nov 30, 2022 1 $19.5K 4 Dec 2, 2022 Head of Finance and Interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Sep 12, 2022 2 $97K 4 Sep 14, 2022 Head of Finance and Interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Jun 24, 2022 1 $4K 4 Jun 28, 2022 Head of Finance and interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Jun 10, 2022 1 $7.8K 4 Jun 10, 2022 Head of Finance and interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Mar 31, 2022 2 $9.9K 4 Apr 4, 2022 Head of Finance and interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Dec 13, 2021 3 $16.4K 4 Dec 15, 2021 Head of Finance and interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Oct 28, 2021 2 $0 4 Nov 1, 2021 Head of Finance and interim Chief Financial Officer
BTTX Better Therapeutics, Inc. Oct 28, 2021 0 $0 3 Nov 1, 2021 Head of Finance and interim Chief Financial Officer Exhibit 24 - Power of Attorney